The global muscle stimulator market was estimated to be USD 0.763 billion in 2023 and is expected to reach at USD 1.24 billion by 2034 with a CAGR of 4.52% during the forecast period 2024-2034. Rising popularity of muscle stimulators among physiotherapists, increasing advancements in medical device technology, growing focus on pain management therapies within sports medicine, surge in prevalence of musculoskeletal disorders, rising demand for wireless & portable muscle stimulators, which can be used in conjunction with smartphones, increasing cases of hip flexor strain, Anterior Cruciate Ligament (ACL) tear, & hamstring strain among athletes, surge in the introduction of innovative devices, and growing approval of advanced muscle stimulator devices by regulatory authorities are some of the key factors boosting the market growth.
Growing approval of advanced muscle stimulator devices by regulatory authorities is predicted to boost the market growth during the forecast period. In clinical and home care settings, physiotherapists are increasingly opting for muscle stimulators over manual methods due to their time-saving nature and enhanced effectiveness. Therefore, in response to the increasing demand for innovative devices, market players are introducing advanced muscle stimulator devices. For instance, in March 2023, Neuro20 Technologies Corp, a company focused on creating wearable medical devices, particularly wireless wearable textiles aimed at treating neuromuscular injuries and illnesses while improving human performance, has disclosed that the U.S. Food and Drug Administration (FDA) has approved the company's 510(k) pre-market approval application for its Neuro20 PRO System.
By product, transcutaneous electrical nerve stimulation (TENS) was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the rise in arthritis cases, advancements in technology, and surge in sports-related injuries. Additionally, Neuromuscular Electrical Stimulation (NMES) is predicted to grow at the fastest CAGR during the forecast period owing to the increasing utilization to restore or substitute motor functions in patients with upper motor neuron damage resulting from stroke or Spinal Cord Injury (SCI) and rising number of novel platform launches by market participants. For instance, in October 2022, Medtronic plc, a prominent figure in healthcare technology worldwide, has unveiled the Medtronic Neurovascular Co-Lab Platform. This platform is aimed at expediting much-needed innovation in stroke care and treatment.
By modality, portable was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the widespread application in preventing muscle deterioration, easing muscle spasms, addressing chronic arthritis-related pain, improving blood circulation, and growing introduction of innovative stimulators. For instance, in November 2023, Motive Health, previously known as CyMedica Orthopedics, has introduced Motive Knee, an FDA-cleared muscle stimulation device designed for knee pain, which is now accessible without a prescription. Additionally, handheld is predicted to grow at the fastest CAGR during the forecast period owing to the ease of use, growing geriatric population, surge in technological developments, and increasing demand for wearable devices.
By application, pain management was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the increasing incidence of chronic pain among elderly individuals, rising demand for safe & effective pain management options, heightened utilization of muscle stimulators for both acute & chronic pain management, and growing prevalence of arthritis. Additionally, neurological disorder is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for stimulation devices, heightened necessity for treating paralyzed patients, and the escalating approval of innovative devices. For instance, in April 2023, Reach Neuro, Inc., a medical equipment manufacturer based in Pittsburgh, Pennsylvania, has been granted breakthrough device designation by the U.S. Food and Drug Administration (FDA) for its Avantis system. This system aims to restore a patient's capacity to control movement and provide treatment for upper body paralysis resulting from strokes.
By end-user, physiotherapy clinics was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the rising inclination of physiotherapists towards stimulators over manual methods, increasing preference for physiotherapy clinics among patients, and growing population suffering from arthritis. Additionally, home care is predicted to grow at the fastest CAGR during the forecast period owing to the escalating need for portable & handheld devices, rising numbers of elderly individuals, and surge in approvals from regulatory agencies. For instance, in November 2023, Zynex, Inc. has announced that it has submitted a 510(k) application for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device to the U.S. Food and Drug Administration ("FDA").
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in government investments for the innovation & development of medical devices, increase in the introduction of new muscle stimulator supplements, growing adoption of advanced technologies and surge in approvals for innovative medical devices. For instance, in March 2024, Lumenis Be, Ltd., is excited to reveal that the popular Facial Muscle Stimulation therapy, which has gained popularity in the United States, will now be available in Canada. Health Canada has authorized the triLift, an innovative device using Dynamic Muscle Stimulation technology (DMSt), as a Medical Device License (MDL). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing uptake of non-invasive & medication-free approaches to pain management, growing awareness of health & fitness, rising adoption of pain management therapies, uptick in sports-related injuries, and growing initiatives from market players. For instance, in March 2022, North Adelaide is introducing the inaugural South Australian establishment of the personal training franchise, SpeedFit. This new studio marks both the debut of SpeedFit in South Australia and the introduction of the first electro muscle stimulation (EMS) workout option for residents of Adelaide.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Growing approval of advanced muscle stimulator devices by regulatory authorities is predicted to boost the market growth during the forecast period. In clinical and home care settings, physiotherapists are increasingly opting for muscle stimulators over manual methods due to their time-saving nature and enhanced effectiveness. Therefore, in response to the increasing demand for innovative devices, market players are introducing advanced muscle stimulator devices. For instance, in March 2023, Neuro20 Technologies Corp, a company focused on creating wearable medical devices, particularly wireless wearable textiles aimed at treating neuromuscular injuries and illnesses while improving human performance, has disclosed that the U.S. Food and Drug Administration (FDA) has approved the company's 510(k) pre-market approval application for its Neuro20 PRO System.
By product, transcutaneous electrical nerve stimulation (TENS) was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the rise in arthritis cases, advancements in technology, and surge in sports-related injuries. Additionally, Neuromuscular Electrical Stimulation (NMES) is predicted to grow at the fastest CAGR during the forecast period owing to the increasing utilization to restore or substitute motor functions in patients with upper motor neuron damage resulting from stroke or Spinal Cord Injury (SCI) and rising number of novel platform launches by market participants. For instance, in October 2022, Medtronic plc, a prominent figure in healthcare technology worldwide, has unveiled the Medtronic Neurovascular Co-Lab Platform. This platform is aimed at expediting much-needed innovation in stroke care and treatment.
By modality, portable was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the widespread application in preventing muscle deterioration, easing muscle spasms, addressing chronic arthritis-related pain, improving blood circulation, and growing introduction of innovative stimulators. For instance, in November 2023, Motive Health, previously known as CyMedica Orthopedics, has introduced Motive Knee, an FDA-cleared muscle stimulation device designed for knee pain, which is now accessible without a prescription. Additionally, handheld is predicted to grow at the fastest CAGR during the forecast period owing to the ease of use, growing geriatric population, surge in technological developments, and increasing demand for wearable devices.
By application, pain management was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the increasing incidence of chronic pain among elderly individuals, rising demand for safe & effective pain management options, heightened utilization of muscle stimulators for both acute & chronic pain management, and growing prevalence of arthritis. Additionally, neurological disorder is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for stimulation devices, heightened necessity for treating paralyzed patients, and the escalating approval of innovative devices. For instance, in April 2023, Reach Neuro, Inc., a medical equipment manufacturer based in Pittsburgh, Pennsylvania, has been granted breakthrough device designation by the U.S. Food and Drug Administration (FDA) for its Avantis system. This system aims to restore a patient's capacity to control movement and provide treatment for upper body paralysis resulting from strokes.
By end-user, physiotherapy clinics was the highest revenue-grossing segment in the global muscle stimulator market in 2023 owing to the rising inclination of physiotherapists towards stimulators over manual methods, increasing preference for physiotherapy clinics among patients, and growing population suffering from arthritis. Additionally, home care is predicted to grow at the fastest CAGR during the forecast period owing to the escalating need for portable & handheld devices, rising numbers of elderly individuals, and surge in approvals from regulatory agencies. For instance, in November 2023, Zynex, Inc. has announced that it has submitted a 510(k) application for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device to the U.S. Food and Drug Administration ("FDA").
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in government investments for the innovation & development of medical devices, increase in the introduction of new muscle stimulator supplements, growing adoption of advanced technologies and surge in approvals for innovative medical devices. For instance, in March 2024, Lumenis Be, Ltd., is excited to reveal that the popular Facial Muscle Stimulation therapy, which has gained popularity in the United States, will now be available in Canada. Health Canada has authorized the triLift, an innovative device using Dynamic Muscle Stimulation technology (DMSt), as a Medical Device License (MDL). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing uptake of non-invasive & medication-free approaches to pain management, growing awareness of health & fitness, rising adoption of pain management therapies, uptick in sports-related injuries, and growing initiatives from market players. For instance, in March 2022, North Adelaide is introducing the inaugural South Australian establishment of the personal training franchise, SpeedFit. This new studio marks both the debut of SpeedFit in South Australia and the introduction of the first electro muscle stimulation (EMS) workout option for residents of Adelaide.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Modality, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Muscle Stimulator Market Report 2023 - 2034
Muscle Stimulator Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Micro Current Electrical Neuromuscular Stimulator
- Transcutaneous Electrical Nerve Stimulation
- Neuromuscular Electrical Stimulation
- Functional Electrical Stimulation
- Burst Mode Alternating Current
- Interferential
- Others
Muscle Stimulator Market Analysis & Forecast by Modality 2023 - 2034 (Revenue USD Bn)
- Portable
- Handheld
- Table Top
Muscle Stimulator Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Musculoskeletal Disorder
- Neurological Disorder
- Pain Management
- Others
Muscle Stimulator Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Physiotherapy Clinics
- Hospitals
- Home Care
- Ambulatory Surgical Centers
- Sports Clinics
Muscle Stimulator Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Muscle Stimulator Market: Product Estimates & Trend Analysis
8. Muscle Stimulator Market: Modality Estimates & Trend Analysis
9. Muscle Stimulator Market: Application Estimates & Trend Analysis
10. Muscle Stimulator Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Muscle Stimulator Market
13. Europe Global Muscle Stimulator Market
14. Asia Pacific Global Muscle Stimulator Market
15. Latin America Global Muscle Stimulator Market
16. MEA Global Muscle Stimulator Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- BioMedical Life Systems Inc.
- OMRON Corporation
- Beurer GmbH.
- EMS Physio Ltd.
- NeuroMetrix Inc.
- Zynex Inc.
- DJO Global Inc.
